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a b s t r a c t
During limb development Pax3 positive myoblasts delaminate from the hypaxial dermomyotome of limb
level somites and migrate into the limb bud where they form the dorsal and ventral muscle masses.
Only then do they begin to differentiate and express markers of myogenic commitment and
determination such as Myf5 and MyoD. However the signals regulating this process remain poorly
characterised. We show that FGF18, which is expressed in the distal mesenchyme of the limb bud,
induces premature expression of both Myf5 and MyoD and that blocking FGF signalling also inhibits
endogenous MyoD expression. This expression is mediated by ERK MAP kinase but not PI3K signalling.
We also show that retinoic acid (RA) can inhibit the myogenic activity of FGF18 and that blocking RA
signalling allows premature induction of MyoD by FGF18 at HH19. We propose a model where
interactions between FGF18 in the distal limb and retinoic acid in the proximal limb regulate the timing
of myogenic gene expression during limb bud development.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Amniote limb muscles are derived from myoblasts that origi-
nate in somites and migrate into developing limb buds (Chevallier
et al., 1977; Christ and Brand-Saberi, 2002). Delamination and
migration of these cells from the ventro-lateral lip of the hypaxial
dermomyotome is regulated by Hepatocyte Growth Factor/Scatter
Factor (HGF/SF) (Dietrich et al., 1999; Scaal et al., 1999) and
requires the paired box transcription factor Pax3 (Franz et al.,
1993). Once in the limb myoblasts migrate to form the dorsal and
ventral muscle masses. Only then do they begin to express the
Myogenic Regulatory Factors (MRFs), basic helix loop helix tran-
scription factors comprising Myf5, MyoD, myogenin and MRF4
which, ultimately, leads to differentiation of mature, functional
myotubes (Buckingham et al., 2003; Mok and Sweetman, 2011).
Myogenesis has been extensively studied during embryo devel-
opment and provides an excellent paradigm to understand how
inductive signals regulate differentiation. Much of this work has
focused on somites and extensive work has shown that interactions
between Wnt, Shh and BMP signalling in both chicken and mouse
embryos are critical for myogenesis (Borycki et al., 1999, 1998;
Hirsinger et al., 1997; Munsterberg et al., 1995; Munsterberg and
Lassar, 1995; Pourquie et al., 1996; Tajbakhsh et al., 1998). However
it is clear that the signalling events that control myogenesis in
developing limbs are distinct from those in somites. It has been
suggested that limb myoblasts differentiate via a default pathway
once they escape inhibitory BMPs (Amthor et al., 1998). Never-
theless other signals are involved in limb myogenesis (Christ and
Brand-Saberi, 2002; Duprez, 2002; Venters et al., 2004) including
ﬁbroblast growth factors (FGFs) (Edom-Vovard et al., 2001; Marics
et al., 2002) and retinoic acid (RA) (Reijntjes et al., 2010) both of
which have been reported to have inductive and repressive roles
depending on concentration and cellular context. Recently Shh has
also been shown to have an important role in the initiation of Myf5
and MyoD expression in limb myoblasts as well as their subsequent
migration (Anderson et al., 2012; Hu et al., 2012).
Several lines of evidence suggest that FGF receptors play important
roles in limb myogenesis (Flanagan-Steet et al., 2000; Lagha et al.,
2008; Marcelle et al., 1995; Marics et al., 2002). Grafting of FGF soaked
beads has been shown to negatively regulate muscle cell differentia-
tion in somites (Sweetman et al., 2006) while retroviral FGF4mediated
expression can inhibit myogenesis in limbs (Edom-Vovard et al., 2001).
However it has not been clearly established which of the FGF ligands
are responsible for this activity in vivo and is further complicated by
the ability of FGFs to induce their own negative regulators, resulting in
complex feedback loops (Eblaghie et al., 2003; Smith et al., 2005).
Although ectopic FGF4 can inhibit limb bud muscle gene expression
(Edom-Vovard et al., 2001) it is normally expressed in the apical
ectodermal ridge (AER) which is probably too far from the developing
myoblasts to play a role (Christen and Slack, 1999) while FGF10, which
is expressed in the limb bud mesenchyme, is not able to induce
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myogenic gene expression in vivo (Ward et al., 2003). Other FGFs
expressed in the limb include FGF8 and FGF2 which, like FGF4, are
expressed in the AER, and FGF12 and FGF13 which are intracellular
FGFs and do not signal via tyrosine kinase receptors (Karabagli et al.,
2002). At least two FGF receptors, FGFR1 and FGFR4, are expressed in
areas of the limb where myoblasts are located (Marcelle et al., 1995;
Sheeba et al., 2010) and loss of function of either of these receptors
disrupts limb muscle formation (Flanagan-Steet et al., 2000; Itoh et al.,
1996; Marics et al., 2002).
We wished to determine which FGF is likely to regulate limb
bud myogenic gene expression in vivo. We identiﬁed FGF18 as a
candidate because it is expressed in the limb bud mesenchyme
(Maruoka et al., 1998; Ohuchi et al., 2000) and can signal through
FGFR4 which is known to play a role in myogenesis (Kwiatkowski
et al., 2008; Marics et al., 2002; Zhang et al., 2006). FGF18 has been
shown to regulate chondrocyte proliferation and hence bone
growth in the developing limb (Liu et al., 2007) as well as hair
follicle growth (Kawano et al., 2005; Leishman et al., 2013) and
lung development (Elluru et al., 2009; Usui et al., 2004) but has
not previously been implicated in myogenesis.
Interactions between retinoic acid and FGF signals have also
been proposed to pattern the proximal–distal axis of the devel-
oping chick limb (Cooper et al., 2011; Mercader et al., 2000;
Roselló-Díez et al., 2011, 2014). While this idea remains contro-
versial (Cunningham et al., 2013) we hypothesised that interac-
tions between these signals could provide a mechanism for
controlling the timing of myoblast commitment and differentia-
tion in the developing chicken limb. In this context it is worth
noting that FGF and RA signalling pathways are known to interact
during axis extension (del Corral et al., 2003) and that FGF18
expression is also regulated by RA signalling in both the trunk
(Zhao and Duester, 2009) and the digits (Zhao et al., 2010).
Our data suggest that FGF18 from the distal limb bud regulates
the timing of expression of the myogenic markers Myf5 and MyoD
through the ERK MAP kinase signalling pathway and that this is
antagonised by high levels of retinoic acid in the proximal limb.
We propose that interactions between these signalling pathways
control the timing of progression of myoblasts from proliferative
precursors to committed myocytes.
Materials and methods
Probes and in situ hybridisation
Dig-11-UTP (Roche) labelled antisense RNA probes were generated
from full length cDNAs for Myf5 and MyoD cloned into pGEM
(Promega) (Sweetman et al., 2008) were linearised with SacII and
transcribed with SP6 RNA polymerase. Myogenin probes were gener-
ated from pBS-SK-Mgn linearised with SalI and transcribed with T7
RNA polymerase. Full length FGF18 was cloned fromwhole D5 embryo
cDNA into pGEM using the following primers: FGF18F: ATGTATT-
CACTGCTCTCC, FGF18-HA-R (also includes sequence for c terminal HA
tag): TAAGCGTAATCTGGAACATCGTATGGGTAACTGGGGTTGGTGGG-
TCG. PCR was performed with Phusion DNA polymerase (NEB),
A-tailed and cloned into pGEM-T Easy. For Dig labeled probe tran-
scription plasmid DNA was linearised with SacII and transcribed with
SP6 RNA polymerase. MRF probes were as described in Sweetman
et al. (2008) and Pax3 probes as in Abu-Elmagd et al. (2010). In situ
hybridisation was as described in Smith et al. (2005).
Immunostaining
Embryos were harvested and dissected in cold PBS and ﬁxed in
4% paraformaldehyde at 4 1C overnight. Embryos were washed in
PBS for 30 min at room temperature and then washed in 0.2%
Triton X-100 at 4 1C overnight. Embryos were washed in PBS for
30 min at room temperature and then incubated in PBS with
Mouse-anti p44/42 MAPK (Erk1/2) (Cell Signalling Technology, cat
no 9102,) diluted 1:50 in PBS at 4 1C for 72 h in darkness. Embryos
were then washed in PBS and incubated in PBS with Alexa Fluor
488 goat anti-mouse IgG2b (Invitrogen) diluted 1:200 at 4 1C
overnight in the dark. Embryos were ﬁxed and imaged on a Leica
MZ10F steromicroscope.
FGF and pharmacological inhibitor beads
Heparin beads (Sigma H-5263) were soaked for 1 h at room
temperature in recombinant human FGF18, FGF4 or FGF10 (Pepro-
tech) at 0.5 mg/ml reconstituted in PBS with 0.1% BSA before
grafting into limb buds. Control beads were soaked in PBS with
0.1% BSA for 1 h. AG 1-X2 beads (BioRad) were incubated in either
4 mg/ml all-trans retinoic acid (Sigma) or the following pharma-
cological inhibitors: 10 mM U0126 (Merck), 10 mM SB203580
(Tocris bioscience), 2 mg/ml BMS493 (Tocris), 10 mM LY294002
(Calbiochem), 10 mM SU5402 (Calbiochem) or 10 mM FIIN 1 hydro-
chloride (Tocris bioscience) all dissolved in DMSO. Control beads
were soaked in DMSO. Beads were soaked in inhibitors for at least
1 h at room temperature in the dark, washed brieﬂy in 2% phenol
red then rinsed in PBS prior to grafting.
Chick embryo manipulations
Fertile chicken White Leghorn eggs were obtained from Henry
Stewart & Co Ltd (Norfolk, UK) and incubated at 37.5 1C until the
desired Hamburger & Hamilton stage was reached. Manipulated
embryos were visualised by injection of Windsor & Newton Black
India Ink diluted 1:500 in PBS under the embryo. Beads were
grafted into slits cut into limb buds with a sharpened tungsten
wire needle. Eggs were re-sealed with sellotape and incubated at
37.5 1C for either 1, 6 or 24 h.
Results
FGF18 expression in developing limb mesenchyme is consistent with a
role in myogenic gene induction
As FGF18 expression has been described in developing chicken
and mouse embryo limbs (Maruoka et al., 1998; Ohuchi et al., 2000)
we ﬁrst conﬁrmed that it is expressed in chick embryos with a
spatio-temporal pattern consistent with a role in myogenesis. We
cloned a full length FGF18 cDNA for in situ hybridisation and
examined its expression from HH stage 18 to HH stage 26, the
period when myoblasts migrate into and differentiate in limb buds.
At HH18 FGF18 is expressed in the tailbud, pharyngeal arches, nasal
placode and isthmus, consistent with previous reports (Fig. 1A)
(Ohuchi et al., 2000). We ﬁrst detected FGF18 in limb buds at HH20
where it is expressed in the distal mesenchyme of both fore- and
hindlimbs (Fig. 1B). Expression of FGF18 is maintained in the distal
mesenchyme from stages HH22 to HH26 (Fig. 1C, D and E) and at
HH26 is also detected in the condensing cartilage of the hind limb
(Fig. 1E). Sections through limb buds at HH22 show expression of
FGF18 distal to the dorsal and ventral muscle masses where Pax3
expressing myoblasts are beginning to differentiate and express
markers such as Myf5 and MyoD (Fig. 1F–I).
Grafting FGF18 beads into developing limbs induces premature
expression of Myf5, MyoD and myogenin
To test directly if FGF18 can induce expression of muscle
markers we grafted beads soaked in recombinant FGF18 protein
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into developing limbs at stages between HH19 and HH21 and
analysed effects on myogenesis by in situ hybridisation with
speciﬁc markers for different stages of muscle development.
Ectopic expression of Myf5 in migratory myoblasts was detected
after six hours incubation with FGF18 at HH19 (6/6 embryos,
Fig. 2A, B and M) and HH21 (7/7 embryos, Fig. 2G, H and N). MyoD
is upregulated by FGF18 after six hours at HH stage 21 (12/12
embryos, Fig. 2I and J) but not at HH stage 19 (12/12 embryos,
Fig. 2C and D). To assess the effects on later markers of myogenesis
we also examined myogenin expression after FGF18 bead grafts at
HH21. Six hours after grafting we did not detect ectopic myogenin
expression (4/4 embryos, Fig. 2E and F) but did after 24 h
incubation with FGF18 beads (5/6 embryos, Fig. 2K and L).
As Pax3 is expressed in proliferative myoblasts and down-
regulated as differentiation proceeds we also examined the effects
of FGF18 on this gene. Although we did not observe large scale
changes in expression in wholemount embryos with FGF18 beads
grafted at HH21 (4/4 embryos) (Fig. 2O) sections through these
limbs did show localised downregulation of Pax3 immediately
adjacent to the FGF18 bead (Fig. 2P).
We also tested the ability of other FGFs to induce ectopic MyoD
expression. FGF4 was able to induce MyoD expression (9/9
embryos, Fig. 2Q) while FGF10 was not (7/7 embryos, Fig. 2R).
Embryos grafted with control beads soaked in 0.1% BSA did not
show ectopic expression ofMyf5 at HH19 (4/4 embryos, Fig. 1S and
T) or HH21 (5/5 embryos Fig. 2U and V). We also did not detect
ectopic MyoD expression following 0.1% BSA bead grafts at HH19
(5/5 embryos, data not shown) or after grafting at HH21 (6/6
embryos, Fig. 1W and X).
FGF18 dependant MyoD expression requires ERK phosphorylation
To identify the signal transduction pathway responsible for
ectopic MyoD expression following FGF18 bead application we
used a phospho speciﬁc antibody staining to detect activiation of
ERK MAP kinase. Within 1 h of bead grafting we detected high
levels of phospho-ERK in the mesenchyme surrounding the bead
(3/3 embryos, Fig. 3A–C). Beads soaked in FGF10 (4/4 embryos,
Fig. 3D–F), which is also expressed in limb bud mesenchyme but
has different receptor speciﬁcity (Zhang et al., 2006), or control
beads soaked in 0.1% BSA (4/4 embryos, Fig. 3G–I) did not induce
ERK phosphorylation.
To conﬁrm that these results were speciﬁc to FGF receptor
activation and not off target effects from FGF beads we co-grafted
FGF18 beads with beads soaked in an inhibitor of all four FGFRs,
FIIN 1 hydrochloride, which was able to block FGF18 induced
MyoD expression (18/19 embryos, Fig. 4A). We also tested SU5402,
another FGFR inhibitor which blocks signalling from FGFR1 and
FGFR3, but this did not prevent FGF18 induced MyoD expression
(8/10 embryos, Fig. 4D).
As MEK is upstream of ERK and is responsible for its phosphor-
ylation we tested if its activity was required for ectopic MyoD
expression induced by FGF18 by grafting FGF18 and beads soaked
in the MEK inhibitor U0126 adjacent to each other in developing
limb buds for 6 h. In these embryos U0126 beads blocked FGF18
induced expression of MyoD (12/13 embryos, Fig. 4B). To conﬁrm
the speciﬁcity of MEK in blocking FGF18 induced MyoD expression
we also co-grafted FGF18 and beads soaked in the PI3K inhibitor
LY294002. In these embryos FGF18 was still able to induce MyoD
expression in the presence of LY294002 (8/11 embryos, Fig. 4C).
Control beads soaked in DMSO did not affect MyoD induction by
FGF18 (6/6 embryos, Fig. 4E).
To test if inhibition of MEK could also block endogenous
expression of MyoD we grafted U0126 beads into embryos at
HH23, the point at which MyoD expression is ﬁrst detected in limb
buds by in situ hybridisation. U0126 grafted limbs had reduced
MyoD expression when compared to contralateral unmanipulated
limbs (8/10 embryos, Fig. 4F and G) while DMSO control beads did
not (10/10 embryos, Fig. 4H and I).
We then grafted beads soaked in either FIIN 1 hydrochloride,
U0126 or DMSO into limb buds at HH21, harvested them after 24 h
and examined MyoD expression by comparing operated limb buds
to contralateral controls. FIIN 1 hydrochloride beads abrogated
MyoD expression, particularly in the dorsal muscle mass (9/11
embryos, Fig. 4J and K) while U0126 beads did not affect MyoD
expression in the majority of cases (17/24 embryos, Fig. 4L and M)
Fig. 1. Expression of FGF18 during limb development is consistent with a role in myogenic differentiation. (A) At HH18 FGF is expressed in the isthmus, pharyngeal arches,
nasal placode and tailbud. (B) FGF18 is ﬁrst detected in limbs at HH20 where is expressed in the distal mesenchyme of the limb bud. (C) and (D) FGF18 expression is
maintained in the distal mesenchyme of the limb bud at HH22 and HH24 and (E) at HH26 is also detected in the condensing cartilage of the zeugopod. (F) Section through
developing forelimb at HH22 showing expression of FGF18 in the distal mesenchyme adjacent to the dorsal and ventral muscle masses shown be expression of Pax3 (G),Myf5
(H) and MyoD (I). ﬂ, forelimb; hl—hindlimb; pa—pharyngeal arches; np—nasal placode; tb—tailbud; i—isthmus; dm—distal mesenchyme; dmm—dorsal muscle mass; vmm—
ventral muscle mass; c-condensing cartilage.
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although localised MyoD downregulation was observed in some
cases (7/24 embryos). Control embryos with DMSO beads had
normal MyoD expression in most cases (15/19 embryos, Fig. 4N
and O).
Retinoic acid prevents FGF18 induced MyoD expression while RA
inhibitors potentiate it
Retinoic acid is known to have both positive and negative
effects on limb muscle differentiation depending on concentration
(Reijntjes et al., 2010) and it has also been suggested that
interactions between retinoic acid and FGF signalling can inﬂuence
proximal–distal limb patterning (Cooper et al., 2011; Mercader et
al., 2000; Roselló-Díez et al., 2011). Therefore we tested if RA
signalling could affect the ability of FGF18 to induce myogenic
gene expression. All trans retinoic acid (ATRA) soaked beads were
grafted into forelimbs at HH21 and embryos harvested after 24 h.
MyoD expression was reduced in these forelimbs compared to
contralateral limbs (9/9 embryos, Fig. 5A and B), consistent with
previous reports (Reijntjes et al., 2010). We then tested the ability
Fig. 2. FGF18 induces MRF expression in limb buds in vivo. FGF18 beads grafted into developing limbs in ovo at HH19 induce Myf5 expression (B) but not MyoD expression
(D) after 6 h incubation. Unmanipulated contralateral limbs from the same embryos are shown in (A) and (C). FGF18 beads grafted into developing limbs in ovo at HH21
induce both Myf5 expression (H) and MyoD (J) expression after 6 h incubation. Unmanipulated contralateral limbs from the same embryos are shown in (G) and (I). FGF18
beads grafted into developing limbs in ovo at HH21 do not induce myogenin after 6 h incubation (F) but do after 24 h (L). Unmanipulated contralateral limbs from the same
embryos are shown in (E) and (K). Transverse sections of Myf5 stained embryos grafted with FGF18 beads at HH19 (M) and HH21 (N) (positions of beads shown by dotted
circles) show expression of Myf5 in migrating myoblasts from hypaxial somites. FGF18 beads grafted into developing limbs in ovo at HH21 does not obviously alter Pax3
expression in wholemount in situ hybridisation (O) but in transverse sections localised downregulation of Pax3 is seen close to the FGF18 bead (P). Beads soaked in FGF4
induce MyoD expression when grafted at HH21 (Q) but FGF10 soaked beads do not (R). Beads soaked in 0.1% BSA do not induce Myf5 expression when grafted at HH19 (T).
BSA beads grafted at HH21 do not induce Myf5 (V) orMyoD (X) expression. Unmanipulated contralateral limbs from the same embryos are shown in (S), (U) and (W). Dotted
lines show outlines of limb buds. Arrows indicate ectopic MRF expression (B, H, J, L, M, N, Q) or loss of Pax3 expression (N)
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of ATRA to block FGF18 induced MyoD expression directly by
grafting FGF18 soaked beads adjacent to ATRA soaked beads into
HH21 limb buds. The majority of these embryos did not show
ectopic MyoD expression (19/25 embryos, Fig. 5C and D). Control
embryos grafted with FGF18 and beads soaked in DMSO at HH21
showed the expected induction of MyoD (6/6 embryos, Fig. 4D).
We grafted beads soaked in BMS493, a retinoic acid antagonist,
into HH19 embryos along with FGF18 soaked beads. In these
embryos we saw ectopic expression of MyoD (8/9 embryos, Fig. 5E
and F) in contrast to embryos grafted with FGF18 alone at HH19
which do not express ectopic MyoD (Fig. 2D). Beads grafted into
HH19 forelimbs soaked in BMS493 did not induce MyoD expres-
sion after 6 h (10/10 embryos, Fig. 5G) and neither did control
beads soaked in DMSO (6/6 embryos, Fig. 5H).
Discussion
Our results show that FGF18 in limb buds can induce expression
of the key regulators of myogenesis, Myf5 and MyoD within 6 h of
bead grafting, and that this is mediated via ERK MAP kinase
signalling. We also demonstrate differing temporal responses in that
Myf5 is induced in both early (HH19) and later (HH21) limb buds
while MyoD expression is only induced at later stages (HH21þ).
Finally we show that ectopically applied retinoic acid can inhibit the
ability of FGF18 to induce MyoD while a retinoic acid antagonist,
BMS493, can potentiate it in early limb buds. We propose that
interactions between these two signals regulate the timing of onset
of Myf5 and MyoD expression in limb myoblasts (Fig. 6A and B).
FGF18 induces myogenic gene expression
Signals inducing myogenic expression have been extensively
studied in somites and both Myf5 and MyoD are known to be
induced by Wnt and Shh signalling in the epaxial myotome
(Borycki et al., 1998; Munsterberg et al., 1995; Tajbakhsh et al.,
1998) and by Wnt and BMP in the hypaxial myotome (Dietrich
et al., 1998; Geetha-Loganathan et al., 2005; Marcelle et al., 1997).
In developing limbs the inductive signals are much less well
characterised although several factors have been shown to inhibit
early myogenesis including HGF/SF (Scaal et al., 1999), retinoic acid
(Reijntjes et al., 2010), BMPs (Amthor et al., 1998) Shh (Duprez et
al., 1998) and Notch (Delﬁni et al., 2000; Mayeuf-Louchart et al.,
2014) while other factors known to induce early myogenic gene
expression in somites, such as Wnts and Shh, appear to regulate
later stages of limb muscle development (Anakwe et al., 2003;
Anderson et al., 2012; Hu et al., 2012). As a result it has been
proposed that limb bud myoblasts undergo differentiation as a
result of the withdrawal of inhibitors of differentiation rather than
in response to inductive signals (Amthor et al., 1998).
A strong candidate for an inducer of myogenic genes in devel-
oping limbs is FGF signalling through FGFR4. FGFR4 is required
during myogenic differentiation of C2C12 cells (Kwiatkowski et al.,
2008), is expressed in myoblasts as they migrate into the limb
(Sheeba et al., 2010) and a dominant negative form of this receptor
can inhibit Myf5, MyoD and MHC expression in limb myoblasts
during development (Marics et al., 2002). Our data are consistent
with a role for FGFR4 as both FGF18 induced and endogenousMyoD
expression was blocked by a pan-FGFR inhibitor (FIIN 1 hydrochlor-
ide) (Zhou et al., 2010) but not SU5402 which is known to block
FGFR1 and 3 (Grand et al., 2004; Mohammadi et al., 1997) but has
not been shown to directly affect FGFR4 activity.
However, it has not been established which of the FGFs
mediates this activity. Our data show that FGF4 or FGF8 soaked
beads can induce MyoD in developing limbs in the same way as
FGF18 (Fig. 2 and data not shown) but these FGFs are normally
restricted to the apical ectodermal ridge, some distance from the
differentiating myoblasts. Although FGFs can act over several cell
diameters (Christen and Slack, 1999) the AER is probably too far
from the myoblasts to be the source of an inductive signal for these
Fig. 3. FGF18 beads induce ERK phosphorylation. FGF18 (A)–(C) beads, grafted into HH21 limb buds and incubated for 1 h induce ERK phosphorylation. FGF10 (D)–(F) or 0.1%
BSA (G)–(I) beads do not induce ERK phosphorylation. (A), (D) and (G) brightﬁeld images, (B), (E) and (F) immunostaining with phospho-ERK speciﬁc antibody, (C), (F),
(I) merged images.
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cells and ERK phosphorylation in response to ridge FGFs does not
seem to extend into the myogenic regions of the limb bud (Corson et
al., 2003). In contrast to our data, previous reports have shown that
FGF4 in limb buds can lead to loss of myogenic gene expression
(Edom-Vovard et al., 2001). We believe that this can be reconciled
with our observations as the manipulations we performed were
different in two important respects; our observations were carried
out over very short time scales, making it likely that this conﬂicting
data was uncovering a later function of FGF signalling, and we used
bead grafts to deliver FGF while Edom-Vovard et al. used RCAS
retroviral misexpression. This makes it possible that we delivered
higher doses of FGF which, in vitro, can lead to a switch between
induction and repression of myogenesis (Pizette et al., 1996). It is
also possible that longer term exposure to FGF results in the
upregulation of negative regulators of FGF signalling such as Sprouty
or MAPK phosphatases (Eblaghie et al., 2003; Ozaki et al., 2001;
Smith et al., 2005) which could also lead to the discrepancy between
these results and those we observe.
Another potential candidate is FGF10 which is expressed in the
limb bud mesenchyme (Ohuchi et al., 1997) but this has been
shown not to induce myogenesis in vivo (Ward et al., 2003) and
does not signal through FGFR4 (Zhang et al., 2006). Based on the
combination of its expression in the limb bud mesenchyme (Fig. 1
and Ohuchi et al., 2000), and its ability to signal through FGFR4
(Ellsworth et al., 2002; Xu et al., 2000) we identiﬁed FGF18 as a
candidate inducer of limb bud myogenesis although our data does
not rule out contributions from other FGFs in inducing limb bud
myogenesis.
One observation from our data is that myogenic induction in
these manipulations was mostly observed proximal to the bead.
Although this might seem to conﬂict with our model, which would
predict that myoblasts in the proximal limb bud should be more
resistant to myogenic induction than more distal cells, this can be
explained by the position of the myoblasts within the limb bud at
these stages. Using Pax3 in situ hybridisation to label these
migratory cells shows that the majority of myoblasts at HH 20/21
Fig. 4. Inhibition of FGF receptors and MEK blocks FGF18 induced ectopic MyoD expression in forelimbs but MEK inhibition does not affect long term induction of
endogenousMyoD. FIIN hydrochloride (A) or U0126 (B) beads grafted adjacent to FGF18 beads at HH21 block induction of ectopic MyoDwhile beads soaked in LY294002 (C),
SU5402 (D) or DMSO (E) do not. Embryos grafted with U0126 beads at HH23 and harvested after 6 h show reduced MyoD expression (G) compared to unoperated
contralateral limbs (F) while control beads soaked in DMSO do not (H) and (I). Embryos grafted with FIIN 1 hydorochloride beads at HH21 and harvested after 24 h at HH26
show reduced MyoD expression (K) compared to contralateral control limbs (J). Beads soaked in U0126 (L) and (M) or DMSO (N) and (O) do not affect MyoD expression.
Asterisks marks position of grafted bead. Arrows indicate ectopic MyoD expression.
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are found proximal to the position of grafted beads (Fig. 6C).
Therefore it is no surprise that we detect the strongest response
in this region of the limb. In addition myogenic cells introduced into
the distal region of the limb bud show reduced myogenesis.
Therefore, it is also likely that signals in the distal limb are also
operating to supress muscle gene expression (Robson and Hughes,
1996). This could also explain why, in normal limb buds, myogen-
esis is seen ﬁrst in the proximal then distal limb while our model,
with proximal RA repressing and distal FGF18 inducing muscle gene
expression, would predict the opposite. Combining our observations
with the previous data showing that the distal limb can repress
myogenesis resolves this conﬂict. There are many signalling mole-
cules in the limb bud which have been shown to inhibit myogenic
gene expression such as BMPs (Amthor et al., 1998), Notch (Delﬁni
et al., 2000), HGF/SF (Scaal et al., 1999) and Shh (Duprez et al., 1998)
and it is likely that interactions between RA, FGF18 and these
repressive factors are also important for myoblast differentiation.
We also observe that in later manipulations loss of MyoD
expression is seen in the dorsal but not the ventral muscle mass.
Although it may be the case that the dorsal and ventral muscle
masses are responding differently to the inhibitors we use, as they
do to Shh signalling (Anderson et al., 2012; Hu et al., 2012), it is
also possible that this merely reﬂects the dorsal position of the
bead following grafting.
FGF18 induced MyoD expression requires ERK signalling
Our data show that FGF18 beads induce phosphorylation of ERK
MAP Kinase within one hour and that blocking this with the MEK
inhibitor U0126 prevents ectopic MyoD expression. Similarly we
show that U0126 can inhibit the onset of endogenous MyoD
expression. However blocking ERK signalling over longer time
scales does not inhibit MyoD and after a 24 h incubation with
U0126 beads manipulated limbs have similar MyoD expression to
Fig. 5. RA signaling interacts with FGF18 induced MyoD expression. ATRA beads grafted into forelimbs at HH21 and incubated for 24 h (B) reduce endogenous MyoD
expression compared to unmanipulated contralateral control limbs (A). Limbs grafted with both FGF18 and ATRA do not show ectopic MyoD expression (D). Unmanipulated
control limbs from the same embryo also show no endogenous MyoD expression. Forelimbs at HH19 with both FGF18 and BMS493 beads grafted for 6 h show ectopic
induction of MyoD (F) compared to contralateral control limbs (E) while HH19 limb grafted with BMS493 alone (G) or DMSO (H) do not show ectopic MyoD. Arrows indicate
ectopic MyoD expression.
Fig. 6. Model of FGF and retinoic acid interactions regulating limb bud myogenesis. (A) At HH 20, prior to MyoD expression, myoblasts expressing Pax3 are migrating from
the ventro-lateral dermomyotome into the limb bud. RALDH in the ﬂank generates retinoic acid in the proximal limb that repressesMyoD expression. (B) At HH23 myoblasts
have migrated further into the limb, away from the source of RA, and the FGF18 expression domain in the distal limb has expanded allowing downregulation of Pax3 and
induction ofMyoD by FGF18 while inhibitory signals prevent premature MyoD expression in the distal limb bud. (C) In situ hybridization for Pax3 at HH21 shows the position
of migrating myoblasts in the proximal limb bud.
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contralateral controls. It is possible that in these embryos the
inhibitor is no longer active after this period of time or that
induction of MyoD by FGF18 is regulating the timing of onset of
MyoD expression rather than being absolutely required for myo-
genesis. Interestingly in FGF18 null mice skeletal development is
also delayed but not abrogated (Liu et al., 2007) suggesting that
the regulation of timing of differentiation may be a conserved
feature of FGF18 function although muscle defects in this mouse
have not been reported. In contrast long term effects on myogen-
esis are seen following grafts of the irreversible FGFR inhibitor FIIN
1 hydrochloride. This could reﬂect different stability of these
inhibitors in vivo or it is possible that there are multiple phases
of FGF signalling that are differently affected by these drugs. In this
scenario U0126 can block the initial induction of MyoD through
the ERK pathway but later induction is driven by FGF signalling
through an alternative signalling pathway.
Interactions between FGF18 and retinoic acid control timing of MyoD
One striking feature of our data are the different temporal
responses of Myf5 and MyoD to FGF18 beads. Myf5 is upregulated
in early limb bud stages while MyoD is only induced prematurely
after HH21; however this can be overcome by co-grafting FGF18
beads adjacent to beads soaked in BMS493, an antagonist of
retinoic acid signalling. This implies that retinoic acid, which is
synthesised in the embryonic ﬂank, prevents premature differen-
tiation of myoblasts as they migrate into the limb. As the limb bud
expands they move away from the RA producing ﬂank and
towards the distal limb which expresses FGF18 as well as retinoic
acid catabolising genes such as CYP26B1 (Reijntjes et al., 2003).
Therefore we propose a model where the timing of limb myoblast
differentiation is controlled by these opposing activities with high
levels of RA in the proximal limb bud maintaining a proliferative
myoblast pool while FGF18 and lower levels of RA in the distal
limb promote MyoD expression and differentiation (see Fig. 6).
The possibility that high concentrations of RA inhibit myogenesis
while lower ones promote it (Reijntjes et al., 2010) could also help
explain the proximal–distal direction of myogenesis, especially
when combined with a distal inhibitory signal. Interestingly, a
similar two signal model of opposing RA and FGF gradients has
been proposed to pattern the proximal–distal limb axis in chicken
embryos (Cooper et al., 2011; Mercader et al., 2000; Roselló-Díez
et al., 2011) although work in mice has challenged this view
(Cunningham et al., 2013).
Differential responses of MRFs to FGF18
Although our data show that FGF18 can induce both Myf5 and
MyoD it is not clear if these are independently regulated or ifMyoD
is downstream of Myf5 given that Myf5 can induce MyoD expres-
sion in chicken (Delﬁni and Duprez, 2004; Sweetman et al., 2008)
and mouse (Relaix et al., 2013) embryos. It is possible that the
developmental delay before migrating myoblasts are competent to
respond to FGF18 and upregulateMyoD is due to a requirement for
Myf5. If this is the case this could explain whyMyf5 can be induced
by FGF18 at HH19 but MyoD is not.
However while Myf5 is expressed before MyoD in chick limbs
there is only partial overlap of these two genes (Delﬁni et al.,
2000). It is also clear from genetic ablation experiments in mice
that there are Myf5 independent muscle cell lineages (Gensch et
al., 2008; Haldar et al., 2008) but not MyoD independent ones
(Wood et al., 2013) while cell labelling and culture experiments
have also suggested that at least two distinct populations of cells
contribute to limb myogenesis (Kablar et al., 2003; Picard and
Marcelle, 2013). It may be the case that the different temporal
responses we observe in these assays are a result of distinct
precursor populations of myoblasts in the developing limb. If so
then we would expect to see Myf5 negative cells in the limb which
respond to FGF18 by expression of MyoD.
An alternative explanation is that the transcriptional regulation
of MyoD is more sensitive to RA mediated repression than Myf5. In
this case ERK activation at HH19 can induce Myf5 but in these cells
MyoD expression is not induced because the inﬂuence of RA at this
time is still too strong, possibly because of interactions between
RA and ERK response elements in the MyoD regulatory regions.
Distinguishing between these possibilities will provide important
insights into the mechanisms of cell fate determination.
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